hVIVO plc (LON:HVO – Get Free Report)’s share price dropped 6.8% during trading on Thursday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Stock Performance
The company has a 50-day moving average price of GBX 23.20 and a two-hundred day moving average price of GBX 26.66. The stock has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Nebius Group: The Rising Star in AI Infrastructure
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
